Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Respiratory syncytial virus immunisation

  • 3 clinical trials
Quick filters

3 Clinical trials

Respiratory syncytial virus immunisation

Recruiting

Safety, Tolerability and Immunogenicity of RSV prefusion F protein 847a and 847b Vaccine in Children 5‑17 Years at High Risk of RSV Disease

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A
  • Sponsor:Pfizer Inc.

Respiratory syncytial virus infection+1

Not yet recruiting

Clesrovimab vs Sodium Chloride for Reducing RSV and Other Respiratory Pathogen Shedding in Healthy Infants

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · Healthy volunteers
  • Substances:Clesrovimab
  • Sponsor:University Of Crete

Respiratory syncytial virus infection+1

Not recruiting

Studying the Effect of Nirsevimab Immunization on Antibody Development After RSV Infection in Healthy Infants

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · Healthy volunteers
  • Substances:Nirsevimab
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
See all trials →
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.